Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grisma Patel

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Seminars in Oncology Nursing|November 26, 2023
Advanced Triple-Negative Breast CancerGrisma Patel, Alison Prince, Mark Harries
Surgical Technology International|July 9, 2016
Application of the Prevena™ Incision Management System Following Complex Ventral Hernia Repairs with Abdominal Wall ReconstructionSala Abdalla, Rachel Rolph, Anjali Rampersad, et al.
Oncology and Therapy|August 7, 2021
An In-Depth Review of Niraparib in Ovarian Cancer: Mechanism of Action, Clinical Efficacy and Future DirectionsMelek Akay, Ionut-Gabriel Funingana, Grisma Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
Eftilagimod Alpha (Soluble LAG3 Protein) Combined with Pembrolizumab as Second-Line Therapy for Patients with Metastatic Head and Neck Squamous Cell CarcinomaMartin Forster, Irene Brana, Antonio L Pousa, et al.
International Journal of Cancer|December 1, 2022
Safe prescribing in cancer patients during the COVID-19 pandemic: A new initiative from the UK Cancer Coronavirus Project (UKCCP) teamNathan Appanna, Grisma Patel, Emma Burke, et al.
Cancers|December 10, 2021
Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London HospitalYien Ning Sophia Wong, Christopher C T Sng, Diego Ottaviani, et al.
British Journal of Cancer|April 20, 2023
The National COVID Cancer Antibody Survey: a hyper-accelerated study proof of principle for cancer researchMatthew Fittall, Justin Liu, James Platt, et al.
International Journal of Cancer|March 10, 2025
Safe prescribing in cancer patients during the COVID-19 pandemic and outcomes following restart of cancer care following SARS-CoV-2 infection: The COV-SPOT initiativeNathan Appanna, Rosie Mew, Sophie Williams, et al.
Contemporary Clinical Trials Communications|November 18, 2024
Adapting the design of the ongoing RAMPART trial in response to external evidence: An example for trials which take many years to run and reportAngela Meade, Elena Frangou, Babak Choodari-Oskooei, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2022
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based studyLennard Y W Lee, Maria C Ionescu, Thomas Starkey, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Seminars in Oncology Nursing|November 26, 2023
Advanced Triple-Negative Breast CancerGrisma Patel, Alison Prince, Mark Harries
Surgical Technology International|July 9, 2016
Application of the Prevena™ Incision Management System Following Complex Ventral Hernia Repairs with Abdominal Wall ReconstructionSala Abdalla, Rachel Rolph, Anjali Rampersad, et al.
Oncology and Therapy|August 7, 2021
An In-Depth Review of Niraparib in Ovarian Cancer: Mechanism of Action, Clinical Efficacy and Future DirectionsMelek Akay, Ionut-Gabriel Funingana, Grisma Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
Eftilagimod Alpha (Soluble LAG3 Protein) Combined with Pembrolizumab as Second-Line Therapy for Patients with Metastatic Head and Neck Squamous Cell CarcinomaMartin Forster, Irene Brana, Antonio L Pousa, et al.
International Journal of Cancer|December 1, 2022
Safe prescribing in cancer patients during the COVID-19 pandemic: A new initiative from the UK Cancer Coronavirus Project (UKCCP) teamNathan Appanna, Grisma Patel, Emma Burke, et al.
Cancers|December 10, 2021
Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London HospitalYien Ning Sophia Wong, Christopher C T Sng, Diego Ottaviani, et al.
British Journal of Cancer|April 20, 2023
The National COVID Cancer Antibody Survey: a hyper-accelerated study proof of principle for cancer researchMatthew Fittall, Justin Liu, James Platt, et al.
International Journal of Cancer|March 10, 2025
Safe prescribing in cancer patients during the COVID-19 pandemic and outcomes following restart of cancer care following SARS-CoV-2 infection: The COV-SPOT initiativeNathan Appanna, Rosie Mew, Sophie Williams, et al.
Contemporary Clinical Trials Communications|November 18, 2024
Adapting the design of the ongoing RAMPART trial in response to external evidence: An example for trials which take many years to run and reportAngela Meade, Elena Frangou, Babak Choodari-Oskooei, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2022
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based studyLennard Y W Lee, Maria C Ionescu, Thomas Starkey, et al.
Pageof 2